Bangkok, 17 July 2026 – The
Securities and Exchange Commission (SEC) has extended the deadline for DOD Biotech Public Company Limited (DOD) to submit its rectified
interim financial statements for the first quarter of 2026, from 27 July
2026 to 14 August 2026.